Today, we’re excited to announce the launch of our BioGenes CHO PRDX1 ELISA Kit! Our kit delivers the sensitivity, CHO-specificity, and regulatory compliance you need to monitor and mitigate this risk.
Key Benefits:
✅ CHO-specific antibodies for maximum selectivity
✅ High sensitivity – LOD ~0.04 ng/mL, LOQ ~0.15 ng/mL
✅ ICH Q2-compliant validation with CVs < 10%
✅ User-friendly workflow – 96-well sandwich ELISA format
✅ Broad compatibility – process and drug substance samples
Applications:
- Monitor PRDX1 in in-process samples
- Use as an orthogonal method alongside total HCP ELISAs
- Strengthening CMC, QC, and release testing strategies
Learn more about the new PRDX1 HCP solution on the dedicated webpage.
And we may be back soon with more good news!